| dbo:abstract |
Nicholas B. Lydon (* 27. Februar 1957) ist ein US-amerikanischer Biochemiker und Geschäftsmann. (de) Nicholas B. Lydon, né le 27 février 1957, est un biochimiste et un homme d'affaires britannique. (fr) Nicholas B. Lydon FRS (born 27 February 1957) is a British scientist and entrepreneur. In 2009, he was awarded the Lasker Clinical Award and in 2012 the Japan Prize for the development of Gleevec, also known as Imatinib, a selective BCR-ABL inhibitor for the treatment of chronic myeloid leukaemia (CML), which converted a fatal cancer into a manageable chronic condition. (en) 尼古拉斯·B·莱登（英語：Nicholas B. Lydon，1957年2月27日－），英国科学家、企业家。他因研发格列卫——一种治疗慢性粒细胞白血病的选择性BCR - ABL抑制剂获得2009年拉斯克奖。莱登在英国利兹大学获生物化学理学士，在邓迪大学获得博士学位。 (zh) |
| dbo:almaMater |
dbr:University_of_Dundee dbr:University_of_Leeds |
| dbo:award |
dbr:Fellow_of_the_Royal_Society dbr:Japan_Prize dbr:Lasker_Award |
| dbo:birthDate |
1957-02-27 (xsd:date) |
| dbo:institution |
dbr:Schering-Plough dbr:Amgen dbr:Novartis |
| dbo:knownFor |
dbr:Imatinib |
| dbo:thumbnail |
wiki-commons:Special:FilePath/Nicholas_Lydon.jpg?width=300 |
| dbo:wikiPageExternalLink |
http://www.theses.com |
| dbo:wikiPageID |
25064040 (xsd:integer) |
| dbo:wikiPageLength |
8829 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1075194215 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Royal_Society dbr:Schering-Plough dbr:Scotland dbr:Biochemistry dbr:Brian_Druker dbr:Research_and_development dbr:University_of_Dundee dbr:University_of_Leeds dbr:Perth_(Scotland) dbc:Living_people dbr:Chronic_myelogenous_leukemia dbr:England dbr:Gastrointestinal_stromal_tumor dbr:Strathallan_School dbr:Kettering_Prize dbr:Protein_kinase dbc:1957_births dbc:Alumni_of_the_University_of_Dundee dbc:Cancer_researchers dbc:Fellows_of_the_Royal_Society dbc:British_company_founders dbr:Drug_discovery dbr:Druggability dbr:GlaxoSmithKline_Prize dbr:Lasker-DeBakey_Clinical_Medical_Research_Award dbr:Warren_Alpert_Foundation_Prize dbr:Amgen dbr:Fellow_of_the_Royal_Society dbr:France dbr:Novartis dbr:Janet_Rowley dbr:Japan_Prize dbr:AACR_Awards dbc:Alumni_of_the_University_of_Leeds dbc:People_educated_at_Strathallan_School dbc:Recipients_of_the_Lasker-DeBakey_Clinical_Medical_Research_Award dbc:British_biochemists dbr:Charles_Sawyers dbr:Lasker_Award dbr:Imatinib dbr:Oncogene dbr:Chronic_myeloid_leukaemia |
| dbp:almaMater |
University of Dundee (en) University of Leeds (en) (en) |
| dbp:awards |
(en) FRS (en) Japan Prize (en) Lasker Clinical Award (en) |
| dbp:birthDate |
1957-02-27 (xsd:date) |
| dbp:knownFor |
(en) Gleevec (en) AnaptysBio (en) BluePrint Medicines (en) |
| dbp:name |
Nicholas Lydon (en) |
| dbp:thesisTitle |
Studies on the hormone-sensitive adenylate cyclase from bovine corpus luteum (en) |
| dbp:thesisUrl |
http://www.theses.com |
| dbp:thesisYear |
1982 (xsd:integer) |
| dbp:wikiPageUsesTemplate |
dbt:Authority_control dbt:Citation_needed dbt:EngvarB dbt:Reflist dbt:Short_description dbt:URL dbt:Use_dmy_dates dbt:Birth_date_and_age dbt:Infobox_scientist dbt:Centred_pull_quote dbt:FRS_2013 |
| dbp:workplaces |
Amgen (en) Schering-Plough (en) (en) Ciba-Geigy (en) |
| dct:subject |
dbc:Living_people dbc:1957_births dbc:Alumni_of_the_University_of_Dundee dbc:Cancer_researchers dbc:Fellows_of_the_Royal_Society dbc:British_company_founders dbc:Alumni_of_the_University_of_Leeds dbc:People_educated_at_Strathallan_School dbc:Recipients_of_the_Lasker-DeBakey_Clinical_Medical_Research_Award dbc:British_biochemists |
| gold:hypernym |
dbr:Scientist |
| rdf:type |
owl:Thing foaf:Person dbo:Person dul:NaturalPerson wikidata:Q19088 wikidata:Q215627 wikidata:Q5 wikidata:Q729 yago:WikicatAmericanPeople yago:WikicatBiochemists yago:WikicatBritishBiochemists dbo:Animal dbo:Eukaryote dbo:Scientist dbo:Species schema:Person yago:WikicatLivingPeople yago:WikicatPeopleEducatedAtStrathallanSchool wikidata:Q901 yago:Acquirer109764201 yago:Alumnus109786338 yago:Associate109816771 yago:Biochemist109854915 yago:CausalAgent100007347 yago:Chemist109913824 yago:Colleague109935990 yago:Honoree110183757 yago:Intellectual109621545 yago:Laureate110249011 yago:LivingThing100004258 yago:Object100002684 yago:Organism100004475 yago:Peer109626238 yago:Person100007846 yago:PhysicalEntity100001930 yago:Recipient109627906 yago:WikicatJapanPrizeLaureates yago:YagoLegalActor yago:YagoLegalActorGeo yago:Scholar110557854 yago:Scientist110560637 yago:Whole100003553 yago:WikicatAlumniOfTheUniversityOfDundee yago:WikicatAlumniOfTheUniversityOfLeeds yago:WikicatFellowsOfTheRoyalSociety |
| rdfs:comment |
Nicholas B. Lydon (* 27. Februar 1957) ist ein US-amerikanischer Biochemiker und Geschäftsmann. (de) Nicholas B. Lydon, né le 27 février 1957, est un biochimiste et un homme d'affaires britannique. (fr) Nicholas B. Lydon FRS (born 27 February 1957) is a British scientist and entrepreneur. In 2009, he was awarded the Lasker Clinical Award and in 2012 the Japan Prize for the development of Gleevec, also known as Imatinib, a selective BCR-ABL inhibitor for the treatment of chronic myeloid leukaemia (CML), which converted a fatal cancer into a manageable chronic condition. (en) 尼古拉斯·B·莱登（英語：Nicholas B. Lydon，1957年2月27日－），英国科学家、企业家。他因研发格列卫——一种治疗慢性粒细胞白血病的选择性BCR - ABL抑制剂获得2009年拉斯克奖。莱登在英国利兹大学获生物化学理学士，在邓迪大学获得博士学位。 (zh) |
| rdfs:label |
Nicholas B. Lydon (de) Nicholas Lydon (fr) Nicholas Lydon (en) 尼古拉斯·莱登 (zh) |
| owl:sameAs |
freebase:Nicholas Lydon yago-res:Nicholas Lydon https://orcid.org/0000-0001-6252-8095 wikidata:Nicholas Lydon dbpedia-de:Nicholas Lydon dbpedia-fr:Nicholas Lydon dbpedia-zh:Nicholas Lydon https://global.dbpedia.org/id/4jzoK |
| prov:wasDerivedFrom |
wikipedia-en:Nicholas_Lydon?oldid=1075194215&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/Nicholas_Lydon.jpg |
| foaf:isPrimaryTopicOf |
wikipedia-en:Nicholas_Lydon |
| foaf:name |
Nicholas Lydon (en) |
| is dbo:wikiPageRedirects of |
dbr:Lydon,_Nicholas |
| is dbo:wikiPageWikiLink of |
dbr:Cancer_(film) dbr:List_of_fellows_of_the_Royal_Society_J,_K,_L dbr:List_of_fellows_of_the_Royal_Society_elected_in_2013 dbr:Strathallan_School dbr:Kettering_Prize dbr:GlaxoSmithKline_Prize dbr:Lasker-DeBakey_Clinical_Medical_Research_Award dbr:Warren_Alpert_Foundation_Prize dbr:History_of_cancer_chemotherapy dbr:Japan_Prize dbr:Charles_Sawyers dbr:Lasker_Award dbr:Imatinib dbr:Lydon,_Nicholas |
| is foaf:primaryTopic of |
wikipedia-en:Nicholas_Lydon |
